These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 19853925

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
    Aggarwal PK, Chandel N, Jain V, Jha V.
    J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
    [Abstract] [Full Text] [Related]

  • 3. Aetiology and physiopathology of preeclampsia and related forms.
    Lorquet S, Pequeux C, Munaut C, Foidart JM.
    Acta Clin Belg; 2010 Apr; 65(4):237-41. PubMed ID: 20954461
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.
    Sahay AS, Patil VV, Sundrani DP, Joshi AA, Wagh GN, Gupte SA, Joshi SR.
    Hypertens Res; 2014 Aug; 37(8):753-8. PubMed ID: 24718301
    [Abstract] [Full Text] [Related]

  • 7. Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles.
    Alahakoon TI, Zhang W, Trudinger BJ, Lee VW.
    J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1854-9. PubMed ID: 24397483
    [Abstract] [Full Text] [Related]

  • 8. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.
    Soto E, Romero R, Kusanovic JP, Ogge G, Hussein Y, Yeo L, Hassan SS, Kim CJ, Chaiworapongsa T.
    J Matern Fetal Neonatal Med; 2012 May; 25(5):498-507. PubMed ID: 21867402
    [Abstract] [Full Text] [Related]

  • 9. A review of the mechanism for poor placentation in early-onset preeclampsia: the role of autophagy in trophoblast invasion and vascular remodeling.
    Saito S, Nakashima A.
    J Reprod Immunol; 2014 Mar; 101-102():80-88. PubMed ID: 23969229
    [Abstract] [Full Text] [Related]

  • 10. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC, Hastie R, Hannan NJ, Cannon P, Tuohey L, Parry LJ, Senadheera S, Illanes SE, Kaitu'u-Lino TJ, Tong S.
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
    Lim JH, Kim SY, Park SY, Yang JH, Kim MY, Ryu HM.
    Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia.
    Zhou CC, Irani RA, Zhang Y, Blackwell SC, Mi T, Wen J, Shelat H, Geng YJ, Ramin SM, Kellems RE, Xia Y.
    Circulation; 2010 Jan 26; 121(3):436-44. PubMed ID: 20065159
    [Abstract] [Full Text] [Related]

  • 15. The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.
    Cheng M, He P, Fu J.
    J Hum Hypertens; 2016 Dec 26; 30(12):788-793. PubMed ID: 27169826
    [Abstract] [Full Text] [Related]

  • 16. [New insights into the pathogenesis of pre-eclampsia: the role of angiogenesis-inhibiting factors].
    Verdonk K, Visser W, Steegers EA, Kappers M, Danser AH, van den Meiracker AH.
    Ned Tijdschr Geneeskd; 2011 Dec 26; 155():A2946. PubMed ID: 21486506
    [Abstract] [Full Text] [Related]

  • 17. Effect of antihypertensive therapy with alpha methyldopa on levels of angiogenic factors in pregnancies with hypertensive disorders.
    Khalil A, Muttukrishna S, Harrington K, Jauniaux E.
    PLoS One; 2008 Jul 23; 3(7):e2766. PubMed ID: 18648513
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Placental stress and pre-eclampsia: a revised view.
    Redman CW, Sargent IL.
    Placenta; 2009 Mar 23; 30 Suppl A():S38-42. PubMed ID: 19138798
    [Abstract] [Full Text] [Related]

  • 20. [Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians].
    Boulanger H, Lefèvre G, Ahriz Saksi S, Achiche J, Bailleul S, Ekoukou D, Drouin D, Sault C, Stawiarski N, Dupuis E.
    Nephrol Ther; 2019 Nov 23; 15(6):413-429. PubMed ID: 30935786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.